Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nanoflex Robotics has developed a next-generation telerobotic platform that uses advanced magnetic navigation to guide ultra-flexible microcatheters through the vasculature. The primary application focus is on remote neurovascular interventions such as thrombectomy for acute ischemic stroke. The company’s technology enables physicians to perform complex procedures remotely with high precision, potentially reducing time-to-treatment and improving patient outcomes. Initial installations are being used for usability testing, in-vivo studies, and physician training at leading research centers like the Jacobs Institute in New York. The company recently received ISO 13485 certification for its quality management system but has not yet reached commercial launch or late-stage clinical trials.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nanoflex Robotics.